Mersana Therapeutics, Inc.
MRSN
$7.68
$0.0250.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.30M | -24.12M | -14.12M | -11.50M | -24.27M |
| Total Depreciation and Amortization | 287.00K | 316.00K | 400.00K | 402.00K | 403.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.47M | 3.55M | 3.65M | 3.96M | 3.99M |
| Change in Net Operating Assets | -2.07M | -9.07M | -9.19M | -1.44M | -1.98M |
| Cash from Operations | -22.60M | -29.33M | -19.25M | -8.58M | -21.86M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | 395.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 27.00M | 50.00M | 28.47M | 5.51M |
| Cash from Investing | 395.00K | 27.00M | 50.00M | 28.47M | 5.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.14M | -3.14M | -2.10M | -23.00K | -47.00K |
| Issuance of Common Stock | 29.00K | -- | 228.00K | 0.00 | 200.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.11M | -3.14M | -1.87M | -23.00K | 153.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.32M | -5.46M | 28.88M | 19.87M | -16.19M |